Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes
- PMID: 6885111
- PMCID: PMC1454222
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes
Abstract
Human polymorphonuclear leucocytes (PMN) incubated with surface-bound immune complexes (IC) release a substance that induces platelet aggregation and serotonin-release. This substance was identified as platelet-activating factor (PAF) on the basis of its sensitivity to phospholipase A2 and of its purification by thin-layer chromatography in identical conditions to those used to purify zymosan-induced PAF. We used two types of substrates to absorb our IC:Sepharose particles to which we coupled human serum albumin, and which were later incubated with specific rabbit antiserum to form surface-bound immune complexes, and human erythrocytes, to which soluble IC can be passively adsorbed. Both types of surface-bound IC were found to stimulate the release of PAF by human PMN in the absence of complement. These results suggest that PMN may play a central role in the early stages of IC-induced inflammation: they recognize IC adsorbed to red cells or to any other cell able to adsorb IC, and they induce the activation of platelets and release of vasoactive amines, which leads to the increase of vascular permeability believed to be essential for extravascular IC deposition.
Similar articles
-
Polymorphonuclear leucocytes release a factor(s) that induces platelet aggregation and ATP release after interaction with insoluble and surface-fixed immune complexes.Clin Exp Immunol. 1982 Sep;49(3):684-94. Clin Exp Immunol. 1982. PMID: 7172501 Free PMC article.
-
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.Br J Pharmacol. 1996 Jul;118(6):1351-8. doi: 10.1111/j.1476-5381.1996.tb15544.x. Br J Pharmacol. 1996. PMID: 8832056 Free PMC article.
-
Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation.Int Arch Allergy Appl Immunol. 1981;64(1):25-41. doi: 10.1159/000232671. Int Arch Allergy Appl Immunol. 1981. PMID: 7450901
-
Human endothelial cell damage induced by interactions between polymorphonuclear leukocytes and immune complex-coated erythrocytes.Clin Immunol Immunopathol. 1987 Sep;44(3):335-47. doi: 10.1016/0090-1229(87)90078-x. Clin Immunol Immunopathol. 1987. PMID: 3621679
-
Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes.Monogr Allergy. 1977;12:13-26. Monogr Allergy. 1977. PMID: 335211 Review.
Cited by
-
Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat.J Clin Invest. 1989 Feb;83(2):669-78. doi: 10.1172/JCI113931. J Clin Invest. 1989. PMID: 2536403 Free PMC article.
-
Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke.Arch Virol. 1986;90(1-2):111-24. doi: 10.1007/BF01314149. Arch Virol. 1986. PMID: 3015074
-
PAF-acether in chronic arthritis.Agents Actions. 1987 Jun;21(1-2):98-103. doi: 10.1007/BF01974929. Agents Actions. 1987. PMID: 3630862
-
Activation of plasma systems and blood cells by endotoxin in rabbits.Inflammation. 1991 Apr;15(2):81-90. doi: 10.1007/BF00917503. Inflammation. 1991. PMID: 1649134
-
Mouse and human neutrophils induce anaphylaxis.J Clin Invest. 2011 Apr;121(4):1484-96. doi: 10.1172/JCI45232. Epub 2011 Mar 23. J Clin Invest. 2011. PMID: 21436586 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources